Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchison China Regulatory News (HCM)

Share Price Information for Hutchison China (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 520.00
Bid: 512.00
Ask: 518.00
Change: -8.00 (-1.52%)
Spread: 6.00 (1.17%)
Open: 528.00
High: 528.00
Low: 520.00
Yest. Close: 528.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.
Date   Source Headline
12th Mar 20187:02 amRNSFinal Results and Key Clinical Programs Update
6th Mar 20187:00 amRNSPhase Ib/II Trial of Epitinib in Glioblastoma
13th Feb 20187:01 amRNSEnrolment completed Ph III FALUCA Fruquintinib
5th Feb 20187:00 amRNSChi-Med to Announce 2017 Final Results
29th Dec 20177:00 amRNSBlock listing Interim Review
29th Dec 20177:00 amRNSTotal Voting Rights
15th Dec 20177:00 amRNSChi-Med Initiates Fruquintinib US Clinical Trials
1st Nov 20179:45 amRNSNotification of Major Holdings
1st Nov 20179:45 amRNSNOTIFICATION OF MAJOR HOLDINGS
31st Oct 20177:00 amRNSFRUTIGA, a Phase III trial of Fruquintinib
30th Oct 20173:30 pmRNSClosing of U.S. Public Offering of ADSs
27th Oct 201712:10 pmRNSChi-Med Announces Over-allotment Option
26th Oct 20177:00 amRNSChi-Med Announces Pricing Raising US$262 million
25th Oct 20177:00 amRNSChi-Med Announces Proposed Offering of ADSs
19th Oct 20179:20 amRNSNotification of Major Interest in Shares
17th Oct 20177:00 amRNSSavolitinib Shows Encouraging Clinical Activity
16th Oct 20177:00 amRNSChi-Med Reports Preliminary Phase II data
12th Oct 20177:30 amRNSAppointment of Director
29th Sep 20177:04 amRNSSavolitinib and Fruquintinib presentations at WCLC
29th Sep 20177:00 amRNSTotal Voting Rights
29th Sep 20177:00 amRNSOral Presentations at CSCO Annual Meeting
31st Aug 201710:15 amRNSDirector's Share Dealing
29th Aug 20177:00 amRNSStart of HMPL 689 Phase I Trial in China
22nd Aug 20179:00 amRNSDirector's Share Dealing
18th Aug 201710:50 amRNSDirectors' Share Dealing
15th Aug 201710:30 amRNSDirectors' Share Dealing
10th Aug 20179:35 amRNSDirector's Share Dealing
7th Aug 20179:45 amRNSDirectors' Share Dealing
31st Jul 20177:00 amRNSChi-Med Reports 2017 Interim Results
30th Jun 20177:00 amRNSTotal Voting Rights
29th Jun 20177:00 amRNSChi-Med to Announce 2017 HY Financial Results
29th Jun 20177:00 amRNSBlocklisting Six Monthly Return
29th Jun 20177:00 amRNSStart of Savolitinib Global PRCC Phase III Trial
22nd Jun 20177:00 amRNSChi-Med starts Ph I/II Trial of HMPL 453 in China
16th Jun 20179:57 amRNSDirector's Share Dealing
12th Jun 20177:00 amRNSFruquintinib NDA for Advanced CRC Filed with CFDA
6th Jun 20177:00 amRNSPhase III Fruquintinib Data presented at ASCO
18th May 20177:00 amRNSChi-Med Presents Clinical Data at ASCO 2017
28th Apr 20171:40 pmRNSTotal Voting Rights
27th Apr 20172:10 pmRNSResults of Annual General Meeting
7th Apr 20177:00 amRNSPre-clinical Data Presented at AACR
31st Mar 20177:00 amRNSTotal Voting Rights
29th Mar 20178:07 amRNSVesting of LTIP awards
28th Mar 201711:00 amRNSGrant of Share Options under Share Option Scheme
27th Mar 20177:00 amRNS2016 Annual Report and Notice of AGM
24th Mar 20177:00 amRNSAppointment of Director
21st Mar 201710:08 amRNSChi-Med to host R&D Briefings
20th Mar 20178:04 amRNSDirectors' Share Dealing
16th Mar 201711:25 amRNSGrant of Awards under Long Term Incentive Plan
13th Mar 20177:00 amRNSPublication of Form 20-F

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.